Current, effectiveness of therapy and outcomes of new coronavirus infection: preliminary analysis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Relevance. Verification of a new coronavirus infection (COVID-19) requires clear algorithms for the diagnosis and treatment of patients, depending on clinical, laboratory and instrumental dates. Timely and informed decisions on optimizing management tactics and prescribing proactive anti-inflammatory therapy before development of a complete symptom complex life threatening conditions are needed in some cases.

Aim of the study. To analyze the course and outcomes of a new coronavirus infection, depending on the initial characteristics of the patients and treatment options.

Materials and methods. A preliminary analysis of the case histories of 129 people hospitalized in the center for treating patients with a new coronavirus infection at North-Western State Medical University n.a. I.I. Mechnikov was made by random sampling. Among the hospitalized patients there were 67 men (51.9%), the average age was 57.9 ± 16.4 years, 62 women (48.1%), and the average age was 60.2 ± 13.6 years. During hospitalization, all patients underwent standard clinical laboratory and instrumental examination, as well as determination of saturation (SpO2), markers of the cytokine storm (CRP, ferritin, AST, D-dimer, fibrinogen, lymphocytes), compute tomography (CT) of the lungs. The effectiveness and safety of therapy was evaluated by the outcome (recovery, death), as well as by the presence of adverse events in the background of the therapy. Statistical processing of the research results was carried out using the Statistica 12 for Windows application software package, the significance of differences between the two relative values was evaluated using the Student t-test (t > 2, p < 0.05).

Results. Fatal outcomes were significantly more frequently recorded among patients of older age groups and males. The presence of concomitant diseases such as obesity, diabetes mellitus, pathology of the cardiovascular system was accompanied by more frequent fatal outcomes. That allows considering comorbidity as a risk factor for severe course and poor prognosis of COVID-19. However, in general, in the presence of the indicated forms of concomitant diseases, it was not possible to establish significant differences with the outcomes of COVID-19, which may be due to an insufficient amount of patients. Predictors of fatal outcome was low values of saturation, the presence of respiratory failure, a significant amount of lung tissue damage (CT-3-4), as well as high values of CRP, ferritin, AST, D-dimer, neutrophilia, lymphopenia, thrombocytopenia. The use of anticytokine drugs (ACD) in complex therapy can be considered a favorable predictor of outcome, which indicates the advisability of wider use. The materials of the study allow not only a preliminary assessment of the course and effectiveness of complex therapy using anticytokine drugs with COVID-19 in patients with comorbid diseases, but also to develop therapeutic and diagnostic algorithms in patients of this category.

About the authors

Sergey A. Sayganov

North-Western State Medical University named after I.I. Mechnikov

Email: sergey.sayganov@szgmu.ru
ORCID iD: 0000-0001-8325-1937
Scopus Author ID: 56512453000

professor, MD, PhD, Head of the Chair of Hospital Therapy and Cardiology n.a. M.S. Kushakovsky, rector of "North-West State Medical University n.a. I.I. Mechnikov" Ministry of Health of Russia, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Vadim I. Mazurov

North-Western State Medical University named after I.I. Mechnikov

Email: maz.nwgmu@yandex.ru
ORCID iD: 0000-0002-0797-2051

D. Sci. (Med.), Prof., RAS academician,  Head of the research institute of Rheumatology  North-Western State Medical University named after I.I. Mechnikov, head of Department of Therapy, Rheumatology, Examination of Temporary Disability and Quality of Medical Care named after E.E.Eichwald FSBEI HE North-Western State Medical University named after I. I. Mechnikov

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Igor G. Bakulin

North-Western State Medical University named after I.I. Mechnikov

Email: igbakulin@yandex.ru
ORCID iD: 0000-0002-6151-2021
SPIN-code: 5283-2032
Scopus Author ID: 6603812937
ResearcherId: P-4453-2014

Dean of the medical faculty, Professor, doctor of medical Sciences, head of the Department of propaedeutics of internal diseases of gastroenterology and dietetics named after S. M. Rys

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Elguja L. Lataria

North-Western State Medical University named after I.I. Mechnikov

Email: Elguja.Lataria@szgmu.ru

MD, PhD, associate Professor, Vice-Rector for Clinical Work, Head Doctor of Clinics North-West State Medical University named after I.I. Mechnikov "Ministry of Health of Russia, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

S A Artyushkin

North-Western State Medical University named after I.I. Mechnikov

Email: Sergei.Artyushkin@szgmu.ru
ORCID iD: 0000-0003-4482-6157

Vice Rector for Academic Affairs of North-Western 
State Medical University named after I.I.Mechnikov,
Saint Petersburg, Russia
Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Olga Yu. Chizhova

North-Western State Medical University named after I.I. Mechnikov

Email: Ochizhova@gmail.com
ORCID iD: 0000-0002-1716-7654

MD, PhD, Professor of the Chair of the Propedeutics of Internal Diseases, Gastroenterology and Dietology n.a. S.M. Ryss North-Western State Medical University n.a. I.I. Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Irina A. Ruslyakova

North-Western State Medical University named after I.I. Mechnikov

Email: Irina.Ruslyakova@szgmu.ru
ORCID iD: 0000-0003-1507-833X

MD, PhD, assistant of the Chair of propaedeutics of internal diseases, gastroenterology and dietetics n.a. S.M. Ryss North-Western State Medical University n.a. I.I. Mechnikov, anesthetist-resuscitator, head of the intensive care unit for the patients of the therapeutic profile of the Clinic North-Western State Medical University n.a. I.I. Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Natalia A. Prokofieva

North-Western State Medical University named after I.I. Mechnikov

Email: Natalya.Prokofeva@szgmu.ru
ORCID iD: 0000-0003-3105-4530

Head of the therapeutic department of the Clinic North-Western State Medical University n.a. I.I. Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Tatiana S. Fil

North-Western State Medical University named after I.I. Mechnikov

Email: Tatyana.Fil@szgmu.ru
ORCID iD: 0000-0002-2859-4942

MD, PhD, Head of the gastroenterological department of the Clinic North-Western State Medical University n.a. I.I. Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Daridzhan B. Tsurtsumiya

North-Western State Medical University named after I.I. Mechnikov

Email: D.Tcurtcumiya@szgmu.ru
ORCID iD: 0000-0001-7806-9364

MD, PhD, associate Professor of the Chair of Internal Medicine, Clinical Pharmacology and Nephrology North-Western State Medical University n.a. I.I. Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Sergey V. Tikhonov

North-Western State Medical University named after I.I. Mechnikov

Email: sergeyvt2702@gmail.com
ORCID iD: 0000-0001-5720-3528
SPIN-code: 6921-5511

MD, PhD, associate Professor of the Chair of Internal Medicine, Clinical Pharmacology and Nephrology North-Western State Medical University n.a. I.I. Mechnikov

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Mariya I. Skalinskaya

North-Western State Medical University named after I.I. Mechnikov

Author for correspondence.
Email: mskalinskaya@yahoo.com
ORCID iD: 0000-0003-0769-8176

Associate proffessor of the Chair of the Propedeutics of Internal Diseases, PhD Gastroenterology and Dietology n.a. S.M. Riss

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Irina A. Rasmagina

North-Western State Medical University named after I.I. Mechnikov

Email: irenerasmagina@gmail.com
ORCID iD: 0000-0003-3525-3289

resident of the Chair of the Propedeutics of Internal Diseases, Gastroenterology and Dietology n.a. S.M. Riss North-Western State Medical University n.a.I.I.Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Marianna K. Alieva

North-Western State Medical University named after I.I. Mechnikov

Email: diezirrhose@gmail.com
ORCID iD: 0000-0002-0763-6111

resident of the Chair of the Propedeutics of Internal Diseases, Gastroenterology and Dietology n.a. S.M. Riss North-Western State Medical University n.a.I.I.Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

E A Trofimov

North-Western State Medical University named after I.I. Mechnikov

Email: trofimov-zeka@mail.ru
ORCID iD: 0000-0003-3236-4485

associate professor, MD, PhD, associate professor of the Сhair of therapy, rheumatology, examination of temporary disability and quality of medical care n.a. E. E. Eichwald North-Western State Medical University n.a. I.I. Mechnikov.

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Nataliay V. Bakulina

North-Western State Medical University named after I.I. Mechnikov

Email: nv_bakulina@mail.ru
ORCID iD: 0000-0003-4075-4096
Scopus Author ID: 7201739080
ResearcherId: N-7299-2014
http://www.researcherid.com/rid/N-7299-2014

professor, MD, PhD, Head of the Chair of Internal Medicine, Clinical Pharmacology and Nephrology North-Western State Medical University n.a. I.I. Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Elena V. Kolmakova

North-Western State Medical University named after I.I. Mechnikov

Email: Elena.Kolmakova@szgmu.ru
ORCID iD: 0000-0002-3438-5004

MD, PhD, associate Professor of the Chair of Internal Medicine, Clinical Pharmacology and Nephrology North-Western State Medical University n.a. I.I. Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Anna D. Sheyko

North-Western State Medical University named after I.I. Mechnikov

Email: knopfchenanka@gmail.com
ORCID iD: 0000-0002-1677-433X

student

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

Lia N. Belousova

North-Western State Medical University named after I.I. Mechnikov

Email: liya-belousova@yandex.ru
ORCID iD: 0000-0003-4778-1767

MD, PhD, associate professor of the Chair of the Propedeutics of Internal Diseases, Gastroenterology and Dietology n.a. S.M. Riss North-Western State Medical University n.a.I.I.Mechnikov, Saint Petersburg, Russia

Russian Federation, 191015, Saint-Petersburg, Kirochnaya street, 41

References

  1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. https://doi.org/10.1056/NEJMoa2001017.
  2. Simmonds P. Rampant C → U hypermutation in the genomes of SARS-CoV-2 and other Coronaviruses: causes and consequences for their short-and long-term evolutionary trajectories. mSphere. 2020;5(3):e00408-20. https://doi.org/10.1128/mSphere.00408-20.
  3. Драпкина О.М., Маев И.В., Бакулин И.Г., и др. Болезни органов пищеварения в условиях пандемии новой коронавирусной инфекции (COVID-19): временные методические рекомендации // Профилактическая медицина. – 2020. – Т. 23. – № 3-2. – С. 120−152. [Drapkina OM, Mayev IV, Bakulin IG, et al. Diseases of the digestive organs in the context of a new coronavirus infection pandemic (COVID-19). Interim guidelines. The Russian journal of Preventive medicine. 2020;23(3-2):120-152. (In Russ.)]. https://doi.org/10.17116/profmed202023032120.
  4. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75(18):2352-2371. https://doi.org/10.1016/ j.jacc.2020.03.031.
  5. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-422. https://doi.org/10.1016/S2213-2600(20)30076-X.
  6. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. 2020;323(13):1239-1242. https://doi.org/10.1001/jama.2020.2648.
  7. Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020;46(5):846-848. https://doi.org/10.1007/s00134-020-05991-x.
  8. Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5(6):529. https://doi.org/10.1016/S2468-1253(20)30084-4.
  9. CDC Covid-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) − United States, February 12 March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-346. https://doi.org/10.15585/mmwr.mm6912e2.
  10. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020. https://doi.org/10.1001/jamacardio.2020.1286.
  11. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):1-11. https://doi.org/10.1001/jamainternmed.2020.0994.
  12. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. JAMA Intern Med. 2020;18(4):844-847. https://doi.org/10.1111/jth.14768.
  13. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-1034. https://doi.org/10.1016/S0140-6736(20)30628-0.
  14. Liu T, Zhang J, Yang Y, et al. The potential role of IL-6 in monitoring severe case of coronavirus disease 2019. medRxiv. 2020. https://doi.org/https://doi.org/10.1101/2020.03.01.20029769.
  15. Inui S, Fujikawa A, Jitsu M, et al. Chest CT findings in cases from the cruise ship “diamond princess” with coronavirus disease 2019 (COVID-19). Radiology: Cardiothoracic Imaging. 2020;2(2). https://doi.org/10.1148/ryct.2020200110. Published Online: Mar 17, 2020.
  16. Авдеев С.Н. Дыхательная недостаточность // Пульмонология: национальное руководство / под ред. А.Г. Чучалина. – М.: ГЭОТАР-Медиа, 2013. – С. 691−749. [Avdeyev SN. Dykhatel’naya nedostatochnost’. In: Pul’monologiya: natsional’noye rukovodstvo. Ed. by A.G. Chuchalin. Moscow: GEOTAR-Media; 2013. Р. 691-749. (In Russ.)]
  17. Временные методические рекомендации Министерства здравоохранения Российской Федерации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 7.0 (03.06.2020). [Vremennyye metodicheskiye rekomendatsii Ministerstva zdravookhraneniya Rossiyskoy Federatsii. Profilaktika, diagnostika i lecheniye novoy koronavirusnoy infektsii (COVID-19). Version 7.0 (03.06.2020). (In Russ.)]. Доступно по: https://static-0.rosminzdrav.ru/system/attachments/attaches/000/050/584/original/03062020_%D0%9CR_COVID-19_v7.pdf. Ссылка активна на 11.06.2020.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Antibacterial drugs prescribed before hospitalization

Download (67KB)
3. Fig. 2. The structure of concomitant pathology

Download (271KB)
4. Fig. 3. Distribution of patients depending on the degree of lung involvement (CT)

Download (42KB)
5. Fig. 4. The volume of lung damage according to CT data, depending on the degree of respiratory failure

Download (97KB)
6. Fig. 5. The use of different classes of drugs at the hospital stage

Download (48KB)
7. Fig. 6. Frequency of use of various anti-cytokine drugs

Download (65KB)
8. Fig. 7. The frequency and structure of adverse events in the use of anticytokine drugs

Download (84KB)
9. Fig. 8. Outcomes of the disease depending on gender

Download (54KB)
10. Fig. 9. Outcomes of the disease depending on body mass index

Download (82KB)
11. Fig. 10. Outcomes of the disease depending on the volume of lung damage (according to CT)

Download (48KB)

Copyright (c) 2020 Sayganov S.A., Mazurov V.I., Bakulin I.G., Lataria E.L., Artyushkin S.A., Chizhova O.Y., Ruslyakova I.A., Prokofieva N.A., Fil T.S., Tsurtsumiya D.B., Tikhonov S.V., Skalinskaya M.I., Rasmagina I.A., Alieva M.K., Trofimov E.A., Bakulina N.V., Kolmakova E.V., Sheyko A.D., Belousova L.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».